Day: April 2, 2021

Ageas publiceert zijn verslagen over 2020 Ageas publiceert vandaag zijn verslaggeving over 2020 bestaande uit twee aparte publicaties:het Jaarverslag 2020, bestaande uit het Verslag van de Raad van Bestuur van Ageas, de Geconsolideerde Jaarrekening van Ageas en de Statutaire Jaarrekening van ageas SA/NV voor 2020; het Activiteitenverslag 2020 dat een overzicht geeft van alle verwezenlijkingen van Ageas in 2020, zijn activiteiten wereldwijd en de toekomstige ambities.De publicaties zijn beschikbaar op de Investeerders pagina’s van de Ageas website en op de specifieke website voor de resultaten van 2020: reporting2020.ageas.com. De jaarresultaten van Ageas voor 2020 werden via het persbericht van 24 februari 2021 bekendgemaakt.  BijlagePdf-versie van het persbericht

Dubuque, IA, April 02, 2021 (GLOBE NEWSWIRE) — Officials of Heartland Financial USA, Inc. (NASDAQ: HTLF) announced today that the company plans to broadcast a conference call detailing its First Quarter 2021 earnings live over the internet at www.htlf.com at 5:00 p.m. ET on Monday, April 26, 2021. Lynn B. Fuller, Executive Operating Chairman; Bruce K. Lee, President and CEO, and Bryan R. McKeag, Executive Vice President and Chief Financial Officer, will conduct the conference call. Financial results will be available on the company’s website on April 26, 2021, after the market closes. There will be a question-and-answer session following the presentation. Shareholders, analysts and other interested parties are invited to join the call:–   To listen to the live call, please dial (866) 928-9948 at least five minutes before start...

Informations relatives au nombre d’actions composant le capital social et au nombre total de droits de vote correspondants Paris La Défense, le 2 avril 2021 – Assystem S.A. (ISIN : FR0000074148 – ASY), annonce aujourd’hui, conformément à l’article L. 233-8 II du Code de commerce et à l’article 223-16 du Règlement général de l’Autorité des marchés financiers, le nombre d’actions composant son capital social et le nombre total de droits de vote correspondants à la date mentionnée dans le tableau ci-après :  Date    Nombre d’actions en circulation    Nombre total de droits de vote  31 mars 2021    15 668 216Droits de vote théoriques : 24 811 868 (y compris actions autodétenues) Droits de vote exerçables : 23 882 672 (déduction faite des actions autodétenues)A PROPOS D’ASSYSTEMAssystem est un groupe international...

SOGECLAIRBusiness corporation with a capital of 3 098 035 EurosHead Office: 7 avenue Albert Durand – 31700 BLAGNAC (France)Tel.: +33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Information concerning the total number of voting rights and shares in the share capitalSection L.233-8 II of French commercial law (“Code de commerce”) and section 223-16 of the general rules of the French Financial Markets Authority (‘“Règlement général de l’Autorité des Marchés Financiers”)DATE Total number of shares in the share capital Total number of voting rights31 March 2021 3,098,035 Total voting rights – brut: 5,050,502    Total voting rights – net*: 4,906,153* net total: total number of voting rights attached to the total number of shares –  shares deprived of voting rights (treasury stock etc.) AttachmentVoting_rights...

SOGECLAIR Société anonyme au capital de 3 098 035 EurosSiège social : 7 avenue Albert Durand – 31700 BLAGNAC (France)Tél. : 33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Informations relatives au nombre total de droits de vote et d’actions composant le capital socialArticle L.233-8 II du Code de commerce et Article 223-16 du Règlement général de l’Autorité des Marchés FinanciersDate d’arrêté des informations Nombre total d’actions composant le capital social Nombre total de droits de vote31 mars 2021 3 098 035 Total brut : 5 050 502    Total net* : 4 906 153* total net :   nombre total de droits de vote attachés au nombre total d’actions                   – actions privées de droit de vote (auto détention …) Pièce jointeDroits de vote au 31 03 2021

CONVERSE, Ind., April 02, 2021 (GLOBE NEWSWIRE) — In accordance with established succession planning, Gene Miles retired from his daily responsibilities as Chief Executive Officer of First Farmers Bank & Trust on March 31, 2021. His impact on the Bank is immeasurable and the growth during his tenure is unparalleled throughout our company history. Gene will continue in his role going forward as President and Chief Executive Officer of First Farmers Financial Corporation ( FFMR ). Bank President Mark “Doc” Holt will serve as President and Chief Executive Officer of the bank going forward. Gene served First Farmers for over 41 years and his career has touched on nearly every capacity within the institution, including branch manager, commercial loan officer, compliance officer, investment officer, marketing officer and accounting...

The Court allowed to transfer ESO shares to Ignitis Grupė AB “Ignitis grupė” (hereinafter – the Company) informs that on 2 April 2021 Vilnius District Court (hereinafter – the Court) made a decision to approve the Company’s statement on the establishment and recognition of a fact of legal significance that the right of ownership of all unsold shares of its subsidiary AB “Energijos skirstymo operatorius” (hereinafter – ESO) during the mandatory buyout must be transferred to the Company and obliged the shares account managers to make records of the transfer of the rights of ownership to the Company. The document of the Court’s decision will be announced here. The Company believes that the Court’s decision is lawful and reasonable and that it fully complies with the requirements of legal acts. The Court allowed the decision to be enforced...

AB “Ignitis grupė” (hereinafter – the Company) informs that on 2 April 2021 Vilnius District Court (hereinafter – the Court) made a decision to approve the Company’s statement on the establishment and recognition of a fact of legal significance that the right of ownership of all unsold shares of its subsidiary AB “Energijos skirstymo operatorius” (hereinafter – ESO) during the mandatory buyout must be transferred to the Company and obliged the shares account managers to make records of the transfer of the rights of ownership to the Company. The document of the Court’s decision will be announced here. The Company believes that the Court’s decision is lawful and reasonable and that it fully complies with the requirements of legal acts. The Court allowed the decision to be enforced urgently, however the Court’s decision may be appealed within...

AB „Ignitis grupė“ (toliau – Bendrovė) informuoja, kad Vilniaus miesto apylinkės teismas (toliau – Teismas) 2021 m. balandžio 2 d. sprendimu tenkino Bendrovės pareiškimą dėl juridinę reikšmę turinčio fakto nustatymo ir pripažino, kad visos privalomo jos dukterinės bendrovės AB „Energijos skirstymo operatorius“ (toliau – ESO) akcijų pardavimo metu neparduotos akcijos yra Bendrovės nuosavybė, bei įpareigojo akcijų sąskaitų tvarkytojus padaryti įrašus apie nuosavybės teisės perėjimą Bendrovei. Su Teismo sprendimo dokumentu bus galima susipažinti čia. Bendrovės vertinimu, Teismo sprendimas yra teisėtas ir pagrįstas, visiškai atitinkantis teisės aktų reikalavimus. Teismas leido sprendimą vykdyti skubiai, tačiau jis gali būti skundžiamas apeliacine tvarka per 30 d. nuo jo priėmimo momento. Atsiskaitymas su smulkiaisiais akcininkais Atsižvelgiant...

NEVE ILAN, Israel, April 02, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration (the “FDA”). “Obtaining 510(k) clearance from the FDA for our single-source Nanox.ARC digital x-ray is a significant step forward along our US regulatory pathway,” stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. “We remain on track to commence system shipments in the fourth quarter of 2021 and the first quarter of 2022 with the goal of finalizing deployment of the initial 15,000 Nanox.ARC systems by the end of 2024.”    “We believe we are well positioned to achieve our goal of democratizing medical imaging...